Table 2.
Results of Transgender/Gender Nonbinary Status Validation by Mode of Screening
| Mode of ascertainment | Total meeting criteria n (%) | Meeting only this criteria n (%) | Verified TGNBa n (%) | Not verified TGNB n (%) | PPV b |
|---|---|---|---|---|---|
| ICD-9- and 10-CM diagnosis codesc | 125 (59.0) | 31 (14.6) | 24 (77.4) | 7 (22.6) | 77.4 |
| Gender-affirming medications | 85 (39.9) | 19 (9.0) | 10 (52.6) | 9 (47.4) | 52.6 |
| Feminizing | 80 (37.7) | 15 (7.0) | 10 (66.7) | 5 (33.3) | 66.7 |
| Masculinizing | 4 (1.9) | 4 (1.9) | 0 (0) | 4 (100.0) | 0 |
| Free-text keywords | 57 (26.8) | 12 (5.7) | 11 (91.7) | 1 (8.3) | 91.7 |
| HIV funding-related demographics | 131 (61.8) | 42 (19.8) | 26 (61.9) | 16 (38.1) | 61.9 |
| >1 of the above | 108 (50.1) | n/a | 107 (99.1) | 1 (0.9) | 99.1 |
a
TGNB = transgender/gender nonbinary
b
PPV = positive predictive value
c
International Classification of Diseases, 9th and 10th Revisions, Clinical Modification